Ultralife Corporation
ULBINASDAQIndustrials● Active
$6.66
$-0.03(-0.45%)
Market Cap$110933416
P/E Ratio—
52W High$9.52
52W Low$4.9
Ultralife Corporation (ULBI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ULBI · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
-$0.03
Est. $0.15 · -120.0%
Revenue
$0.05B
Est. $0.05B · -9.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ULBI reports quarterly as a NASDAQ-listed Electrical Equipment & Parts company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | $0.19 | — | — | — | $0.06B | — |
| ▼ Q2 FY2026 | May 8, 2026 | $0.15 | -$0.03 | -120.0% | $0.05B | $0.05B | -9.5% |
| ▼ Q1 FY2026 | Mar 10, 2026 | $0.24 | $0.12 | -50.0% | $0.05B | $0.06B | -14.9% |
| ▼ Q4 FY2025 | Nov 18, 2025 | $0.21 | -$0.07 | -133.3% | $0.04B | $0.05B | -18.2% |
| ▼ Q3 FY2025 | Aug 7, 2025 | $0.22 | $0.07 | -68.2% | $0.05B | $0.05B | -8.4% |
| ▼ Q2 FY2025 | May 9, 2025 | $0.15 | $0.13 | -13.3% | $0.05B | $0.05B | -6.9% |
| ▼ Q2 FY2025 | Apr 1, 2025 | $0.15 | $0.01 | -93.3% | $0.04B | $0.04B | +9.6% |
| ▼ Q4 FY2024 | Nov 8, 2024 | $0.21 | $0.01 | -95.2% | $0.04B | $0.05B | -21.6% |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
$0.19
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026Miss
EPS Actual
-$0.03
EPS Est.
$0.15
EPS Surpr.
-120.0%
Revenue
$0.05B
Q1 FY2026
Mar 10, 2026Miss
EPS Actual
$0.12
EPS Est.
$0.24
EPS Surpr.
-50.0%
Revenue
$0.05B
Q4 FY2025
Nov 18, 2025Miss
EPS Actual
-$0.07
EPS Est.
$0.21
EPS Surpr.
-133.3%
Revenue
$0.04B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
$0.07
EPS Est.
$0.22
EPS Surpr.
-68.2%
Revenue
$0.05B
Q2 FY2025
May 9, 2025Miss
EPS Actual
$0.13
EPS Est.
$0.15
EPS Surpr.
-13.3%
Revenue
$0.05B
Q2 FY2025
Apr 1, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.15
EPS Surpr.
-93.3%
Revenue
$0.04B
Q4 FY2024
Nov 8, 2024Miss
EPS Actual
$0.01
EPS Est.
$0.21
EPS Surpr.
-95.2%
Revenue
$0.04B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.27 | $0.27 | $0.27 | 1 |
| Q3 FY2026 | $0.23 | $0.23 | $0.23 | 1 |
| Q2 FY2026 | $0.19 | $0.19 | $0.19 | 1 |
| Q1 FY2026 | $0.15 | $0.15 | $0.15 | 1 |
| Q4 FY2025 | $0.24 | $0.24 | $0.24 | 1 |
| Q3 FY2025 | $0.21 | $0.21 | $0.21 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 8, 2026 | -120.0% | $7.05 | $5.97 | -15.32% |
| ▼ Q1 FY2026 | Mar 10, 2026 | -50.0% | $5.33 | $5.73 | +7.50% |
| ▼ Q4 FY2025 | Nov 18, 2025 | -133.3% | $5.54 | $5.05 | -8.84% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -68.2% | $8.16 | $6.77 | -17.03% |
| ▼ Q2 FY2025 | May 9, 2025 | -13.3% | $4.88 | $5.05 | +3.48% |
| ▼ Q2 FY2025 | Apr 1, 2025 | -93.3% | $5.38 | $5.05 | -6.13% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -95.2% | $9.28 | $7.98 | -14.01% |
| ▲ Q3 FY2024 | Jul 25, 2024 | +57.1% | $11.37 | $10.91 | -4.05% |
Q2 FY2026-15.32%
Report Date
May 8, 2026
EPS Beat/Miss
-120.0%
Price Before
$7.05
Price After
$5.97
Q1 FY2026+7.50%
Report Date
Mar 10, 2026
EPS Beat/Miss
-50.0%
Price Before
$5.33
Price After
$5.73
Q4 FY2025-8.84%
Report Date
Nov 18, 2025
EPS Beat/Miss
-133.3%
Price Before
$5.54
Price After
$5.05
Q3 FY2025-17.03%
Report Date
Aug 7, 2025
EPS Beat/Miss
-68.2%
Price Before
$8.16
Price After
$6.77
Q2 FY2025+3.48%
Report Date
May 9, 2025
EPS Beat/Miss
-13.3%
Price Before
$4.88
Price After
$5.05
Q2 FY2025-6.13%
Report Date
Apr 1, 2025
EPS Beat/Miss
-93.3%
Price Before
$5.38
Price After
$5.05
Q4 FY2024-14.01%
Report Date
Nov 8, 2024
EPS Beat/Miss
-95.2%
Price Before
$9.28
Price After
$7.98
Q3 FY2024-4.05%
Report Date
Jul 25, 2024
EPS Beat/Miss
+57.1%
Price Before
$11.37
Price After
$10.91
Avg Beat Reaction-4.05%
Avg Miss Reaction-7.19%
Beat Rate1 / 8 quarters
Largest Move-17.03% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ULBI ends December
Ultralife Corporation (ULBI) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $-0.03 — missing the analyst consensus of $0.15 by -120.0%. The next ULBI earnings date is expected around September 1, 2026.
Each quarter, investors track ULBI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ULBI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ULBI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ULBI earnings · 5 questionsUltralife Corporation's next earnings report is expected around September 1, 2026. ULBI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ULBI historically reports after market close (AMC).
ULBI earnings datewhen is ULBI earningsULBI next earnings datewhen does ULBI report earningsULBI earnings calendar
▸ Source: FMP · Ultralife Corporation SEC filings · US GAAP · Ultralife Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026